PAR — Par Drugs and Chemicals Balance Sheet
0.000.00%
- IN₹1.06bn
- IN₹644.45m
- IN₹1.04bn
Annual balance sheet for Par Drugs and Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 162 | 222 | 367 | 276 | 418 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 217 | 212 | 185 | 211 | 169 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 436 | 494 | 596 | 549 | 643 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 344 | 387 | 413 | 389 | 372 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 787 | 889 | 1,016 | 1,194 | 1,292 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 149 | 140 | 124 | 166 | 137 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 188 | 176 | 160 | 204 | 172 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 599 | 712 | 856 | 990 | 1,120 |
| Total Liabilities & Shareholders' Equity | 787 | 889 | 1,016 | 1,194 | 1,292 |
| Total Common Shares Outstanding |